JP2001518516A - 避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用 - Google Patents

避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用

Info

Publication number
JP2001518516A
JP2001518516A JP2000514666A JP2000514666A JP2001518516A JP 2001518516 A JP2001518516 A JP 2001518516A JP 2000514666 A JP2000514666 A JP 2000514666A JP 2000514666 A JP2000514666 A JP 2000514666A JP 2001518516 A JP2001518516 A JP 2001518516A
Authority
JP
Japan
Prior art keywords
gdf
antibody
sequence
amino acid
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000514666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001518516A5 (enExample
Inventor
リー，セ−ジン
Original Assignee
ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン filed Critical ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン
Publication of JP2001518516A publication Critical patent/JP2001518516A/ja
Publication of JP2001518516A5 publication Critical patent/JP2001518516A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000514666A 1997-10-06 1998-10-06 避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用 Pending JP2001518516A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/946,092 1997-10-06
US08/946,092 US6030617A (en) 1993-01-12 1997-10-06 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
PCT/US1998/021199 WO1999017797A1 (en) 1997-10-06 1998-10-06 Use of growth differenciation factor-9 (gdf-9) as a contraceptive

Publications (2)

Publication Number Publication Date
JP2001518516A true JP2001518516A (ja) 2001-10-16
JP2001518516A5 JP2001518516A5 (enExample) 2006-01-05

Family

ID=25483945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000514666A Pending JP2001518516A (ja) 1997-10-06 1998-10-06 避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用

Country Status (6)

Country Link
US (1) US6030617A (enExample)
EP (1) EP1021201A4 (enExample)
JP (1) JP2001518516A (enExample)
AU (1) AU757563B2 (enExample)
CA (1) CA2306452A1 (enExample)
WO (1) WO1999017797A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4676600A (en) * 1999-04-30 2000-11-17 Curis, Inc. Morphogen-induced enhancement of fertility
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
JP2008521891A (ja) * 2004-12-02 2008-06-26 アグリサーチ・リミテッド 排卵の調節
EP2228070B1 (en) 2005-07-18 2016-09-07 Adelaide Research & Innovation Pty Ltd Modulation of granulosa cell apoptosis
CN101410132A (zh) * 2006-03-28 2009-04-15 惠氏公司 用于治疗骨疾病的gdf-9/bmp-15调节剂
CA3058678A1 (en) * 2017-02-01 2018-08-09 Newsouth Innovations Pty Limited Gamete-secreted growth factors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015966A1 (en) * 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-9
CA2171546A1 (en) * 1993-10-08 1995-04-20 Se-Jin Lee Growth differentiation factor-10
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone

Also Published As

Publication number Publication date
AU1071499A (en) 1999-04-27
AU757563B2 (en) 2003-02-27
US6030617A (en) 2000-02-29
WO1999017797A1 (en) 1999-04-15
CA2306452A1 (en) 1999-04-15
EP1021201A4 (en) 2004-09-15
EP1021201A1 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
US6365402B1 (en) Growth differentiation factor-9
US7534432B2 (en) Methods of treating musculodegenerative disease with an antibody that binds growth differentiation factor-8
US7198790B2 (en) Growth differentiation factor-5
US5808007A (en) Growth differentiation factor-3
EP0776337B1 (en) Growth differentiation factor-11
US6204047B1 (en) Growth differentiation factor-10
EP0770089B1 (en) Growth differentiation factor-12
JPH11508125A (ja) 繊維芽細胞増殖因子相同因子−１（ｆｈｆ−１）および使用方法
US6524802B1 (en) Methods of detecting growth differentiation factor-14
US5821056A (en) Growth differentiation factor-9
JP2001518516A (ja) 避妊薬としての増殖分化因子−９（ｇｄｆ−９）の使用
US6391565B2 (en) Methods of detecting growth differentiation factor-3
JP2000509965A (ja) 繊維芽細胞増殖因子相同因子―３（ｆｈｆ―３）および使用方法
US7098323B1 (en) Growth differentiation factor-16
HK1068013A (en) Growth differentiation factor-5
HK1072781A (en) Growth differentiation factor-3
HK1059441A (en) Growth differentiation factor-8

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051004

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090212

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090219

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090413

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090420

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090714